> On March 28, 2020, FDA issued an EUA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and used for certain hospitalized patients with COVID-19.
Aha, so on March 19 trump stated “immediately” by which he may actually have intended to convey (but did not explicitly state) a somewhat later date, which turned out to be March 28.
First, I note in passing that this time delay may have had ramifications for some patients in the time period between March 19 and March 28.
Second, I think Trump has a habit of announcing the completion of some tasks slightly before their actual completion. (Personally, I am not an advocate of this habit.)
Thirdly, this may still render medically “inoperative” the Nevada and Michigan Governors’ orders concerning HCQ...
...Anyway, thanks for the info, correction and link!
Following Trump's direction, the FDA approved a "Compassionate Use" exemption for hydroxychloroquine to be used to treat COVID-19 patients on March 19. 10 days later, that was expanded to "emergency use authorization", effectively allowing doctors to prescribe the drug to COVID-19 patients as they see fit.
The drugs were already FDA approved and therefore available for off-label use. This approval appears to be more of an emergency on-label approval. I would welcome more informed commentary on that.